A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT05970497 · RECRUITING

Trial details

NCT number: NCT05970497
Sponsor: Krystal Biotech, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Melanoma Stage III Melanoma Stage IV Cutaneous Melanoma

Start date: 2023-10-31
Primary completion: 2027-07-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.